IL1B and diabetes mellitus: demonstrated that in a diabetes model, the protein expression levels of caspase-11 and GSDMD-N in podocytes were increased, and the expression of podocyte markers nephrin and podocin were decreased, podocyte loss and foot process fusion, promoting the expression of inflammatory factors such as NF-κB, IL-1β and IL-18 (140).